Thiolated chitosan hydrogel containing taurine |
Interconnected pores, biocompatibility, biodegradability, sustained release of taurine |
Peripheral nerve gap |
[8] |
Chitosan conduits filled with simvastatin/Pluronic F-127 hydrogel |
Scaffold support, increased neurotrophic factors |
Peripheral nerve gap |
[9] |
Carboxymethyl chitosan hydrogel (radiation-induced crosslinking) |
Biocompatibility, antimicrobial properties, hydrophilic properties, scaffold support |
Peripheral nerve regeneration |
[10] |
Injectable black phosphorus nanosheets and lipoic acid-modified chitosan hydrogel loaded with tazarotene (LAMC/BP@TA) |
Conductivity, angiogenic potential, neurogenic potential |
Spinal cord injury |
[13] |
Substance P-conjugated chitosan hydrochloride hydrogel (CSCl-SP) |
Stability of SP, angiogenesis, extracellular matrix deposition, nerve regeneration |
Full-thickness skin defects |
[21] |
Chitosan tubes prefilled with aligned fibrin nanofiber hydrogel (AFG) |
Mimics nerve ECM, supports adhesion and proliferation of Schwann cells, promotes axonal growth |
Facial nerve injury |
[39] |
Chitosan/beta-glycerophosphate/salt hydrogel with aligned conductive nanofibers (polycaprolactone/gelatin/SWCNTs) |
Conductivity, mechanical properties matching neural tissue, interconnected structure |
Nerve tissue regeneration |
[55] |